Bracebridge Capital LLC’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.28M Hold
2,705,304
0.25% 18
2025
Q4
$13.9M Hold
2,705,304
0.45% 13
2025
Q3
$22.2M Hold
2,705,304
1.16% 9
2025
Q2
$24.7M Hold
2,705,304
1.32% 13
2025
Q1
$26.2M Hold
2,705,304
1.77% 6
2024
Q4
$35.8M Hold
2,705,304
2.53% 8
2024
Q3
$32.2M Hold
2,705,304
5.25% 3
2024
Q2
$32.9M Hold
2,705,304
5.96% 5
2024
Q1
$33.1M Sell
2,705,304
-1,655,220
-38% -$24.2M 4.08% 6
2023
Q4
$50.1M Hold
4,360,524
10.79% 4
2023
Q3
$39.8M Hold
4,360,524
6.32% 3
2023
Q2
$33.8M Sell
4,360,524
-54,737
-1% -$509K 18.54% 1
2023
Q1
$57M Sell
4,415,261
-2,179,804
-33% -$27.9M 15.2% 2
2022
Q4
$66M Sell
6,595,065
-386,322
-6% -$2.7M 6.16% 3
2022
Q3
$47.2M Hold
6,981,387
8.31% 4
2022
Q2
$57.3M Buy
+6,981,387
New +$65M 9.08% 3

Other funds holding ALVO

Bracebridge Capital LLC's ALVO Position: Q1 2026 in Review

Bracebridge Capital LLC held its Alvotech (ALVO) position steady in Q1 2026 at 2,705,304 shares worth $9.28M. The position accounts for 0.25% of the portfolio, ranked #18.

Bracebridge Capital LLC first reported a position in ALVO in Q2 2022 and has held it in 16 quarters since. The position peaked at $66M in Q4 2022. 57 funds tracked by Wall St. Rank hold ALVO as of Q1 2026.

  • Bracebridge Capital LLC held 2,705,304 shares of Alvotech worth $9.28M as of Q1 2026.
  • Bracebridge Capital LLC left its Alvotech share count unchanged in Q1 2026.
  • Alvotech made up 0.25% of Bracebridge Capital LLC's portfolio in Q1 2026, its #18 holding.
  • Bracebridge Capital LLC first reported a position in Alvotech in Q2 2022 and has held it in 16 quarters since.
  • Bracebridge Capital LLC's Alvotech position peaked at $66M in Q4 2022.
  • 57 funds tracked by Wall St. Rank held Alvotech as of Q1 2026.

Based on Bracebridge Capital LLC's 13F filing for Q1 2026, filed 15 May 2026.